ArticleInternational journal of behavioral medicine2026
mHealth Low-Carbohydrate Type 2 Diabetes Intervention Positively Impacts Sleep Quality and Psychosocial Outcomes.
Article in International journal of behavioral medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo examine the 3-month change of a mHealth low-carbohydrate dietary (LCD) application (app) on sleep quality and psychosocial outcomes in people living with type 2 diabetes (T2D). The aim is to understand the broader impact of the LCD app in the Australian primary care context as an adjunct to standard clinical management of T2D.
methodsThe single arm pre-post study recruited community-based people living with T2D, with web access from around Australia, referred via registered supporting general practitioners (GPs). Following informed consent, participants obtained access to the Defeat Diabetes app, which provided education and resources on the LCD approach and support for ongoing management of T2D. Participants self-reported dietary data and validated questionnaires assessed sleep quality (B-PSQI), quality of life (QoL) (EQ-5D-5L), diabetes-related distress (PAID-5), and self-efficacy in diabetes self-management (PDSMS). Univariate regression models examined changes from baseline to 3 months.
resultsThe present study included 99 participants (mean age 59 ± 11 years, 55 females). Mean carbohydrate intake reduced from baseline to 3 months as a proportion of overall energy intake (-14%kJ/day, 95% CI -17 to -11). Self-reported perceived health status (6, 95% CI 1 to 11), self-efficacy (5, 95% CI 4 to 7), and diabetes-related distress scores (-2.0, 95% CI -3 to -1) improved over 3 months, and there were nonsignificant improvements in sleep quality.
conclusionPeople with T2D who used a mHealth LCD app significantly improved their perceived health status, diabetes-related distress, and self-efficacy in diabetes self-management scores after 3 months. PRACTICE IMPLICATIONS: mHealth LCD apps should be considered useful adjuncts to current medical management of T2D.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.